Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from TrivarX Limited ( (AU:TRI) ) is now available.
TrivarX Limited has issued over 2.4 million ordinary fully paid shares to settle consulting fees, with shares priced between $0.011 and $0.017 each. This issuance was conducted without disclosure to investors under the Corporations Act, and the company confirms compliance with relevant provisions, ensuring no excluded information affects investor assessments.
More about TrivarX Limited
TrivarX Limited is a mental health technology company focused on pioneering the use of objective measures for early detection and screening of mental health conditions. Founded in Australia, it operates from offices in Perth and Minneapolis and is listed on the Australian Securities Exchange and trades on the OTCQB Venture Market.
Average Trading Volume: 1,380,042
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$6.17M
See more data about TRI stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “…Overlook a Lack of Earnings Power”: UBS Analysts Target Intel Stock (NASDAQ:INTC), Stock Gains
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test
- “Direct Result of Your Feedback….” Microsoft Stock (NASDAQ:MSFT) Slips as The Option to Skip Updates Emerges